Your browser doesn't support javascript.
loading
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.
Yu, Lan; Toriseva, Mervi; Afshan, Syeda; Cangiano, Mario; Fey, Vidal; Erickson, Andrew; Seikkula, Heikki; Alanen, Kalle; Taimen, Pekka; Ettala, Otto; Nurmi, Martti; Boström, Peter J; Kallajoki, Markku; Tuomela, Johanna; Mirtti, Tuomas; Beumer, Inès J; Nees, Matthias; Härkönen, Pirkko.
  • Yu L; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Toriseva M; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Afshan S; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Cangiano M; GenomeScan, 2333 BZ Leiden, The Netherlands.
  • Fey V; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Erickson A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford 0X3 9DU, UK.
  • Seikkula H; Department of Urology, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Alanen K; Department of Pathology, Turku University Hospital, 20520 Turku, Finland.
  • Taimen P; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Ettala O; Department of Pathology, Turku University Hospital, 20520 Turku, Finland.
  • Nurmi M; Department of Urology, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Boström PJ; Department of Urology, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Kallajoki M; Department of Urology, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Tuomela J; Department of Pathology, Turku University Hospital, 20520 Turku, Finland.
  • Mirtti T; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20520 Turku, Finland.
  • Beumer IJ; HUS Diagnostic Center and Research Program in Systems Oncology (ONCOSYS), Helsinki University Hospital and University of Helsinki, 00014 Helsinki, Finland.
  • Nees M; GenomeScan, 2333 BZ Leiden, The Netherlands.
  • Härkönen P; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, 20520 Turku, Finland.
Cancers (Basel) ; 14(2)2022 Jan 07.
Article en En | MEDLINE | ID: mdl-35053442
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article